Pipeline Therapeutics
Latest round
- Series C
Last raised
- Feb 2021
Total raised
- $110M
Investors
- 12
About Pipeline Therapeutics
Based in California, US, and founded in 2017, Pipeline Therapeutics Inc. operates as a biotechnology company that develops small molecules neuroregeneration that includes synaptogenesis, remyelination, and axonal repair. In 2018, Carmine Stengone was appointed as the president and CEO. Mr., Senior Director of Business Development of Phenomix Corporation, and serve a position in Anadys Pharmaceuticals and Johnson & Johnson Pharmaceutical Research and Development. The company is comprised of scientific & clinical advisors and scientist to develop PIPE-505, a small molecule gamma-secretase inhibitor (GSI) that treat mild-to-moderate sensorineural hearing loss (SNHL) associated with cochlear synaptopathy. It also develops PIPE-307, a neuro-generation process that focuses on remyelination and axonal repair that address a range of neurological disorders including multiple sclerosis. The company also offers a portfolio of programs that provides treatment for neurological disorders and conditions. The company's revenue is generated by offering its product that focuses on small molecules in neuro-regeneration such as Synaptogenesis, Remyelination, and Axonal Repair.
Who invested in Pipeline Therapeutics
12 investors across 2 rounds
See all investors in Pipeline Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pipeline Therapeutics
Who invested in Pipeline Therapeutics?
Pipeline Therapeutics has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pipeline Therapeutics raised?
Pipeline Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pipeline Therapeutics last raise money?
Pipeline Therapeutics's most recent round on record is a Series C, in Feb 2021.
What does Pipeline Therapeutics do?
Based in California, US, and founded in 2017, Pipeline Therapeutics Inc.
Where is Pipeline Therapeutics headquartered?
Pipeline Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Pipeline Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pipeline Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Pipeline Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.